{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:22:05Z","timestamp":1791602525642,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004578","name":"Ministerstvo Pr\u016fmyslu a Obchodu","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004578","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007452","name":"Ministerstvo Pr\u00e1ce a Soci\u00e1ln\u00edch V\u011bc\u00ed \u010cesk\u00e9 Republiky","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007452","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Japanese Society for Alternatives to Animal Experiments"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00204-021-03101-4","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T08:02:26Z","timestamp":1624780946000},"page":"2755-2768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Optimization of the IL-2 Luc assay for immunosuppressive drugs: a novel in vitro immunotoxicity test with high sensitivity and predictivity"],"prefix":"10.1007","volume":"95","author":[{"given":"Yutaka","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Terui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizu","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0632-2388","authenticated-orcid":false,"given":"Setsuya","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,27]]},"reference":[{"issue":"5","key":"3101_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00204-011-0693-2","volume":"85","author":"S Adler","year":"2011","unstructured":"Adler S, Basketter D, Creton S et al (2011) Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol 85(5):367\u2013485. https:\/\/doi.org\/10.1007\/s00204-011-0693-2","journal-title":"Arch Toxicol"},{"issue":"3","key":"3101_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1152\/physiolgenomics.00025.2005","volume":"21","author":"RD Barber","year":"2005","unstructured":"Barber RD, Harmer DW, Coleman RA, Clark BJ (2005) GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genom 21(3):389\u2013395. https:\/\/doi.org\/10.1152\/physiolgenomics.00025.2005","journal-title":"Physiol Genom"},{"issue":"37","key":"3101_CR3","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.3748\/wjg.v17.i37.4166","volume":"17","author":"K Bradford","year":"2011","unstructured":"Bradford K, Shih DQ (2011) Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease. World J Gastroenterol 17(37):4166\u20134173. https:\/\/doi.org\/10.3748\/wjg.v17.i37.4166","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3101_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0014-4827(85)90157-0","volume":"157","author":"DR Edwards","year":"1985","unstructured":"Edwards DR, Denhardt DT (1985) A study of mitochondrial and nuclear transcription with cloned cDNA probes. Changes in the relative abundance of mitochondrial transcripts after stimulation of quiescent mouse fibroblasts. Exp Cell Res 157(1):127\u2013143","journal-title":"Exp Cell Res"},{"issue":"4","key":"3101_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/1547691X.2010.509848","volume":"7","author":"V Galbiati","year":"2010","unstructured":"Galbiati V, Mitjans M, Corsini E (2010) Present and future of in vitro immunotoxicology in drug development. J Immunotoxicol 7(4):255\u2013267. https:\/\/doi.org\/10.3109\/1547691X.2010.509848","journal-title":"J Immunotoxicol"},{"issue":"2","key":"3101_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","volume":"41","author":"V Gandhi","year":"2002","unstructured":"Gandhi V, Plunkett W (2002) Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet 41(2):93\u2013103. https:\/\/doi.org\/10.2165\/00003088-200241020-00002","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"3101_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/15476910590965832","volume":"2","author":"A Gennari","year":"2005","unstructured":"Gennari A, Ban M, Braun A et al (2005) The use of in vitro systems for evaluating immunotoxicity: the report and recommendations of an ECVAM workshop. J Immunotoxicol 2(2):61\u201383. https:\/\/doi.org\/10.1080\/15476910590965832","journal-title":"J Immunotoxicol"},{"issue":"3","key":"3101_CR301","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.toxlet.2010.02.006","volume":"194","author":"C Haglund","year":"2010","unstructured":"Haglund C, Aleskog A, Hakansson LD, Hoglund M, Jacobsson S, Larsson R, Lindhagen E (2010) The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing. Toxicol Lett 194(3):102\u2013107. https:\/\/doi.org\/10.1016\/j.toxlet.2010.02.006","journal-title":"Toxicol Lett"},{"issue":"5","key":"3101_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.tiv.2014.02.013","volume":"28","author":"Y Kimura","year":"2014","unstructured":"Kimura Y, Fujimura C, Ito Y, Takahashi T, Aiba S (2014) Evaluation of the Multi-ImmunoTox Assay composed of 3 human cytokine reporter cells by examining immunological effects of drugs. Toxicol in Vitro 28(5):759\u2013768. https:\/\/doi.org\/10.1016\/j.tiv.2014.02.013","journal-title":"Toxicol in Vitro"},{"issue":"7","key":"3101_CR9","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.tiv.2015.07.006","volume":"29","author":"Y Kimura","year":"2015","unstructured":"Kimura Y, Fujimura C, Ito Y et al (2015) Optimization of the IL-8 Luc assay as an in vitro test for skin sensitization. Toxicol in Vitro 29(7):1816\u20131830. https:\/\/doi.org\/10.1016\/j.tiv.2015.07.006","journal-title":"Toxicol in Vitro"},{"issue":"6","key":"3101_CR10","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00204-018-2199-7","volume":"92","author":"Y Kimura","year":"2018","unstructured":"Kimura Y, Fujimura C, Ito Y, Takahashi T, Terui H, Aiba S (2018) Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. Arch Toxicol 92(6):2043\u20132054. https:\/\/doi.org\/10.1007\/s00204-018-2199-7","journal-title":"Arch Toxicol"},{"key":"3101_CR11","doi-asserted-by":"publisher","first-page":"104832","DOI":"10.1016\/j.tiv.2020.104832","volume":"66","author":"Y Kimura","year":"2020","unstructured":"Kimura Y, Yasuno R, Watanabe M et al (2020) An international validation study of the IL-2 Luc assay for evaluating the potential immunotoxic effects of chemicals on T cells and a proposal for reference data for immunotoxic chemicals. Toxicol in Vitro 66:104832. https:\/\/doi.org\/10.1016\/j.tiv.2020.104832","journal-title":"Toxicol in Vitro"},{"key":"3101_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/978-1-60761-401-2_26","volume":"598","author":"DP Lankveld","year":"2010","unstructured":"Lankveld DP, Van Loveren H, Baken KA, Vandebriel RJ (2010) In vitro testing for direct immunotoxicity: state of the art. Methods Mol Biol 598:401\u2013423. https:\/\/doi.org\/10.1007\/978-1-60761-401-2_26","journal-title":"Methods Mol Biol"},{"issue":"14","key":"3101_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/pros.20815","volume":"68","author":"R Mori","year":"2008","unstructured":"Mori R, Wang Q, Danenberg KD, Pinski JK, Danenberg PV (2008) Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate 68(14):1555\u20131560. https:\/\/doi.org\/10.1002\/pros.20815","journal-title":"Prostate"},{"issue":"12","key":"3101_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s004030050471","volume":"291","author":"JG Oliveira","year":"1999","unstructured":"Oliveira JG, Prados RZ, Guedes AC, Ferreira PC, Kroon EG (1999) The housekeeping gene glyceraldehyde-3-phosphate dehydrogenase is inappropriate as internal control in comparative studies between skin tissue and cultured skin fibroblasts using Northern blot analysis. Arch Dermatol Res 291(12):659\u2013661","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"3101_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/toxsci\/kfg188","volume":"75","author":"A Pessina","year":"2003","unstructured":"Pessina A, Albella B, Bayo M et al (2003) Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicol Sci 75(2):355\u2013367. https:\/\/doi.org\/10.1093\/toxsci\/kfg188","journal-title":"Toxicol Sci"},{"issue":"2","key":"3101_CR300","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/toxsci\/kfi250","volume":"87","author":"IN Rich","year":"2005","unstructured":"Rich IN, Hall KM (2005) Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay. Toxical Sci 87(2):427\u2013441. https:\/\/doi.org\/10.1093\/toxsci\/kfi250","journal-title":"Toxical Sci"},{"issue":"3","key":"3101_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.taap.2011.04.017","volume":"254","author":"R Saito","year":"2011","unstructured":"Saito R, Hirakawa S, Ohara H et al (2011) Nickel differentially regulates NFAT and NF-kappaB activation in T cell signaling. Toxicol Appl Pharmacol 254(3):245\u2013255. https:\/\/doi.org\/10.1016\/j.taap.2011.04.017","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"3101_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/jat.3079","volume":"35","author":"PC Schmeits","year":"2015","unstructured":"Schmeits PC, Shao J, van der Krieken DA et al (2015) Successful validation of genomic biomarkers for human immunotoxicity in Jurkat T cells in vitro. J Appl Toxicol 35(7):831\u2013841. https:\/\/doi.org\/10.1002\/jat.3079","journal-title":"J Appl Toxicol"},{"issue":"2","key":"3101_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/toxsci\/kft151","volume":"135","author":"J Shao","year":"2013","unstructured":"Shao J, Katika MR, Schmeits PC et al (2013) Toxicogenomics-based identification of mechanisms for direct immunotoxicity. Toxicol Sci 135(2):328\u2013346. https:\/\/doi.org\/10.1093\/toxsci\/kft151","journal-title":"Toxicol Sci"},{"issue":"3","key":"3101_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00204-013-1179-1","volume":"88","author":"J Shao","year":"2014","unstructured":"Shao J, Berger LF, Hendriksen PJ, Peijnenburg AA, van Loveren H, Volger OL (2014) Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol 88(3):673\u2013689. https:\/\/doi.org\/10.1007\/s00204-013-1179-1","journal-title":"Arch Toxicol"},{"issue":"1","key":"3101_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/1547691X.2015.1016635","volume":"13","author":"J Shao","year":"2016","unstructured":"Shao J, Stout I, Hendriksen PJ, van Loveren H, Peijnenburg AA, Volger OL (2016a) Protein phosphorylation profiling identifies potential mechanisms for direct immunotoxicity. J Immunotoxicol 13(1):97\u2013107. https:\/\/doi.org\/10.3109\/1547691X.2015.1016635","journal-title":"J Immunotoxicol"},{"issue":"7","key":"3101_CR21","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00204-015-1585-7","volume":"90","author":"J Shao","year":"2016","unstructured":"Shao J, Stout I, Volger OL, Hendriksen PJ, van Loveren H, Peijnenburg AA (2016b) Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants. Arch Toxicol 90(7):1685\u20131694. https:\/\/doi.org\/10.1007\/s00204-015-1585-7","journal-title":"Arch Toxicol"},{"issue":"2","key":"3101_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/toxsci\/kfr237","volume":"124","author":"T Takahashi","year":"2011","unstructured":"Takahashi T, Kimura Y, Saito R et al (2011) An in vitro test to screen skin sensitizers using a stable THP-1-derived IL-8 reporter cell line, THP-G8. Toxicol Sci 124(2):359\u2013369. https:\/\/doi.org\/10.1093\/toxsci\/kfr237","journal-title":"Toxicol Sci"},{"issue":"2\u20133","key":"3101_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0168-1656(99)00163-7","volume":"75","author":"O Thellin","year":"1999","unstructured":"Thellin O, Zorzi W, Lakaye B et al (1999) Housekeeping genes as internal standards: use and limits. J Biotechnol 75(2\u20133):291\u2013295","journal-title":"J Biotechnol"},{"issue":"1","key":"3101_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/abio.1999.4085","volume":"270","author":"J Winer","year":"1999","unstructured":"Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270(1):41\u201349. https:\/\/doi.org\/10.1006\/abio.1999.4085","journal-title":"Anal Biochem"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03101-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-021-03101-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03101-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T09:10:52Z","timestamp":1626945052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-021-03101-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,27]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["3101"],"URL":"https:\/\/doi.org\/10.1007\/s00204-021-03101-4","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,27]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}